Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,572 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Codesign and implementation of an equity-promoting national health literacy programme for people living with inflammatory bowel disease (IBD): a protocol for the application of the Optimising Health Literacy and Access (Ophelia) process.
Hawkins M, Massuger W, Cheng C, Batterham R, Moore GT, Knowles S, Nadarajah RG, Raven L, Osborne RH. Hawkins M, et al. Among authors: moore gt. BMJ Open. 2021 Aug 26;11(8):e045059. doi: 10.1136/bmjopen-2020-045059. BMJ Open. 2021. PMID: 34446478 Free PMC article.
Variable impact of CD39 in experimental murine colitis.
Künzli BM, Berberat PO, Dwyer K, Deaglio S, Csizmadia E, Cowan P, d'Apice A, Moore G, Enjyoji K, Friess H, Robson SC. Künzli BM, et al. Among authors: moore g. Dig Dis Sci. 2011 May;56(5):1393-403. doi: 10.1007/s10620-010-1425-9. Epub 2010 Oct 9. Dig Dis Sci. 2011. PMID: 20936356
Visceral adiposity predicts post-operative Crohn's disease recurrence.
Holt DQ, Moore GT, Strauss BJ, Hamilton AL, De Cruz P, Kamm MA. Holt DQ, et al. Among authors: moore gt. Aliment Pharmacol Ther. 2017 May;45(9):1255-1264. doi: 10.1111/apt.14018. Epub 2017 Feb 28. Aliment Pharmacol Ther. 2017. PMID: 28244124 Clinical Trial.
Immunomodulator use does not prevent first loss of response to anti-tumour necrosis factor alpha therapy in inflammatory bowel disease: long-term outcomes in a real-world cohort.
Varma P, Rajadurai AS, Holt DQ, Devonshire DA, Desmond CP, Swan MP, Nathan D, Shelton ET, Prideaux L, Sorrell C, Rusli F, Crantock LRF, Dev A, Ratnam DT, Pianko S, Moore GT. Varma P, et al. Intern Med J. 2019 Jun;49(6):753-760. doi: 10.1111/imj.14150. Intern Med J. 2019. PMID: 30381884
3,572 results